Gastrointestinal Cancer Pain

  • Daniel Pak
  • Joseph C. HungEmail author


Many varied pain treatment options exist for pain syndromes secondary to gastrointestinal malignancies and its associated treatments. Systemic therapy using the WHO analgesic ladder is a reasonable initial choice even for practitioners without special training in pain management. Unfortunately, many of these medications are either insufficient when used as monotherapy or associated with intolerable medication-related adverse side effects. In the sections below, we will focus on some techniques that may be considered for common pain syndromes associated with gastrointestinal malignancies.


Gastrointestinal neoplasms Metastasis Cancer pain Pain management Palliative care 


  1. 1.
    Chiu TY, Hu WY, Chen CY. Prevalence and severity of symptoms in terminal cancer patients: a study in Taiwan. Support Care Cancer Off J Multinatl Assoc Support Care Cancer. 2000;8:311–3.Google Scholar
  2. 2.
    Daut RL, Cleeland CS. The prevalence and severity of pain in cancer. Cancer. 1982;50:1913–8.CrossRefGoogle Scholar
  3. 3.
    Donnelly S, Walsh D, Rybicki L. The symptoms of advanced cancer: identification of clinical and research priorities by assessment of prevalence and severity. J Palliat Care. 1995;11:27–32.PubMedGoogle Scholar
  4. 4.
    Portenoy RK, et al. Pain in ovarian cancer patients. Prevalence, characteristics, and associated symptoms. Cancer. 1994;74:907–15.CrossRefGoogle Scholar
  5. 5.
    Vainio A, Auvinen A. Prevalence of symptoms among patients with advanced cancer: an international collaborative study. J Pain Symptom Manag. 1996;12:3–10.CrossRefGoogle Scholar
  6. 6.
    Greenwald HP, Bonica JJ, Bergner M. The prevalence of pain in four cancers. Cancer. 1987;60:2563–9.CrossRefGoogle Scholar
  7. 7.
    Bruera E, Portenoy R (eds.). Cancer pain assessment and management. Cambridge UK: Cambridge University Press; 2009. ISBN: 978-0521879279Google Scholar
  8. 8.
    Sykes N, Bennet M, Yuan C. Clinical pain management. 2nd Edition. Cancer Pain. Boca Raton, FL: CRC Press; 2008. ISBN: 978-0340940075.Google Scholar
  9. 9.
    Grahm AL, Andrén-Sandberg A. Prospective evaluation of pain in exocrine pancreatic cancer. Digestion. 1997;58:542–9.CrossRefGoogle Scholar
  10. 10.
    Deraco M, Laterza B, Kusamura S, Baratti D. Updated treatment of peritoneal carcinomas: a reviewMinerva Chir. 2007;62:459–76.PubMedGoogle Scholar
  11. 11.
    Suzuki M, et al. Sensation of abdominal pain induced by peritoneal carcinomatosis is accompanied by changes in the expression of substance P and μ-opioid receptors in the spinal cord of mice. Anesthesiology. 2012;117:847–56.CrossRefGoogle Scholar
  12. 12.
    Russo P. Urologic emergencies in the cancer patient. Semin Oncol. 2000;27:284–98.PubMedGoogle Scholar
  13. 13.
    Nduka CC, Monson JRT, Menzies-Gow N, Darzi A. Abdominal wall metastases following laparoscopy. Br J Surg. 1994;81:648–52.CrossRefGoogle Scholar
  14. 14.
    Foley KM. Pain syndromes in patients with cancer. Med Clin North Am. 1987;71:169–84.CrossRefGoogle Scholar
  15. 15.
    Borad MJ, et al. Skeletal metastases in pancreatic cancer: a retrospective study and review of the literature. Yale J Biol Med. 2009;82:1–6.PubMedPubMedCentralGoogle Scholar
  16. 16.
    Ahn JB, Ha TK, Kwon SJ. Bone metastasis in gastric cancer patients. J Gastric Cancer. 2011;11:38–45.CrossRefGoogle Scholar
  17. 17.
    Roth ES, et al. Does colon cancer ever metastasize to bone first? A temporal analysis of colorectal cancer progression. BMC Cancer. 2009;9:274.CrossRefGoogle Scholar
  18. 18.
    Santini D, et al. Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study. Ann Oncol Off J Eur Soc Med Oncol ESMO. 2012;23:2072–7.CrossRefGoogle Scholar
  19. 19.
    Brihaye J, Ectors P, Lemort M, Van Houtte P. The management of spinal epidural metastases. Adv Tech Stand Neurosurg. 1988;16:121–76.CrossRefGoogle Scholar
  20. 20.
    Mercadante S, Villari P, Ferrera P, Arcuri E, David F. Opioid switching and burst ketamine to improve the opioid response in patients with movement-related pain due to bone metastases. Clin J Pain. 2009;25:648–9.CrossRefGoogle Scholar
  21. 21.
    Luger NM, et al. Efficacy of systemic morphine suggests a fundamental difference in the mechanisms that generate bone cancer vs inflammatory pain. Pain. 2002;99:397–406.CrossRefGoogle Scholar
  22. 22.
    Quasthoff S, Hartung HP. Chemotherapy-induced peripheral neuropathy. J Neurol. 2002;249:9–17.CrossRefGoogle Scholar
  23. 23.
    Boelens OB, Scheltinga MR, Houterman S, Roumen RM. Management of anterior cutaneous nerve entrapment syndrome in a cohort of 139 patients. Ann Surg. 2011;254:1054–8.CrossRefGoogle Scholar
  24. 24.
    Akhnikh S, de Korte N, de Winter P. Anterior cutaneous nerve entrapment syndrome (ACNES): the forgotten diagnosis. Eur J Pediatr. 2014;173:445–9.CrossRefGoogle Scholar
  25. 25.
    Kinsella TJ, et al. Threshold dose for peripheral neuropathy following intraoperative radiotherapy (IORT) in a large animal model. Int J Radiat Oncol. 1991;20:697–701.CrossRefGoogle Scholar
  26. 26.
    Yi SK, et al. Development of a standardized method for contouring the lumbosacral plexus: a preliminary dosimetric analysis of this organ at risk among 15 patients treated with intensity-modulated radiotherapy for lower gastrointestinal cancers and the incidence of radiation-induced lumbosacral plexopathy. Int J Radiat Oncol Biol Phys. 2012;84:376–82.CrossRefGoogle Scholar
  27. 27.
    Wj M. Surgical management of radiation enteropathy. Surg Clin North Am. 1991;71:977–90.CrossRefGoogle Scholar
  28. 28.
    Eisenberg E, Carr DB, Chalmers TC. Neurolytic celiac plexus block for treatment of cancer pain: a meta-analysis. Anesth Analg. 1995;80:290–5.PubMedGoogle Scholar
  29. 29.
    Polati E, et al. Prospective randomized double-blind trial of neurolytic coeliac plexus block in patients with pancreatic cancer. Br J Surg. 1998;85:199–201.CrossRefGoogle Scholar
  30. 30.
    Rykowski JJ, Hilgier M. Efficacy of neurolytic celiac plexus block in varying locations of pancreatic cancer: influence on pain relief. Anesthesiology. 2000;92:347–54.CrossRefGoogle Scholar
  31. 31.
    Cameron T. Safety and efficacy of spinal cord stimulation for the treatment of chronic pain: a 20-year literature review. J Neurosurg Spine. 2004;100:254–67.CrossRefGoogle Scholar
  32. 32.
    Kapural L, Rakic M. Spinal cord stimulation for chronic visceral pain secondary to chronic non-alcoholic pancreatitis. J Clin Gastroenterol. 2008;42:750–1.CrossRefGoogle Scholar
  33. 33.
    Kim JK, Hong SH, Kim M-H, Lee J-K. Spinal cord stimulation for intractable visceral pain due to chronic pancreatitis. J Korean Neurosurg Soc. 2009;46:165.CrossRefGoogle Scholar
  34. 34.
    Khan YN, Raza SS, Khan EA. Application of spinal cord stimulation for the treatment of abdominal visceral pain syndromes: case reports. Neuromodulation Technol Neural Interface. 2005;8:14–27.CrossRefGoogle Scholar
  35. 35.
    Saito O, et al. Ketamine and N-acetylaspartylglutamate peptidase inhibitor exert analgesia in bone cancer pain. Can J Anaesth J Can Anesth. 2006;53:891–8.CrossRefGoogle Scholar
  36. 36.
    Jackson K, et al. Burst’ ketamine for refractory cancer pain: an open-label audit of 39 patients. J Pain Symptom Manag. 2001;22:834–42.CrossRefGoogle Scholar
  37. 37.
    Mercadante S, Villari P, Ferrera P. Burst ketamine to reverse opioid tolerance in cancer pain. J Pain Symptom Manag. 2003;25:302–5.CrossRefGoogle Scholar
  38. 38.
    Mercadante S, Arcuri E, Tirelli W, Casuccio A. Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: a randomized, controlled, double-blind, crossover, double-dose study. J Pain Symptom Manage. 2000;20:246–52.CrossRefGoogle Scholar
  39. 39.
    Patil S, Anitescu M. Efficacy of outpatient ketamine infusions in refractory chronic pain syndromes: a 5-year retrospective analysis. Pain Med Malden Mass. 2012;13:263–9.CrossRefGoogle Scholar
  40. 40.
    Kosharskyy B, Almonte W, Shaparin N, Pappagallo M, Smith H. Intravenous infusions in chronic pain management. Pain Physician. 2013;16:231–49.PubMedGoogle Scholar
  41. 41.
    Day M. Sympathetic blocks: the evidence. Pain Pract Off J World Inst Pain. 2008;8:98–109.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Massachusetts General HospitalBostonUSA
  2. 2.Memorial Sloan Kettering Cancer CenterAnesthesiology and Critical Care MedicineNew YorkUSA

Personalised recommendations